| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Burroughs W |
Letter From A Master Addict To Dangerous Drugs |
British Journal of A... |
1956 |
| Winter CA, Flataker L |
Further experiments on the performance of trained rats treated with ly... |
J. Pharmacol. Exper.... |
1957 |
| Hofmann A |
Rapport sur une auto-expérience avec le Psilocybe mexicana Heim |
Les champignons hall... |
1958 |
| Monnier M |
Action de la Psilocybine sur le cerveau du lapin |
Experientia |
1959 |
| Ernst AM |
Relation between the structure of certain methoxyphenylethylaminederiv... |
Psychopharmacologia |
1965 |
| Der Marderosian AH |
Nomenclatural History of the Morning Glory, Ipomoea violacea (L.) |
Taxon |
1965 |
| Pahnke WN, Kurland AA, Go... |
LSD-assisted psychotherapy with terminal cancer patients |
Psychedelic Drugs |
1969 |
| Pahnke WN, Kurland AA, Go... |
LSD-assisted psychotherapy with terminal cancer patients |
Curr Psychiatr Ther |
1969 |
| Shields PJ, Eccleston D |
Evidence for the Synthesis and Storage of 5-Hydroxytryptamine in Two S... |
J Neurochem |
1973 |
| Wallis DI, Woodward B |
The depolarizing action of 5-hydroxytryptamine on sympathetic ganglion... |
Brit..Pharmacol. |
1973 |
| Nomura J, Hisamatsu K, Ma... |
Stress and Cerebro-Hepatic Axis with Special Reference to Steroids Met... |
Psychoneuroendocrino... |
1973 |
| Stone TW |
Further evidence for a dopomine receptor stimulating action of an ergo... |
Brain Research |
1974 |
| Frontali M |
A Pharmacological Analysis of Processes Underlying Differential Respon... |
Behav. Biology |
1976 |
| Anton PG, Duncan ME, McGr... |
An Analysis of the Anatomical Basis for the Mechanical Response to Mot... |
J.Physiol. |
1977 |
| Kräuchi K, Feer H, Lichts... |
Specific in vivo Binding of d-LSD in Rat Brain |
Experientia |
1978 |
| Savona G, Paternostro MP,... |
Splendidin, a New trans-Clerodane from Salvia splendens |
Journal of the Chemi... |
1979 |
| Connell DJ, Middlemiss DN... |
Further evidence for an interaction of propranolol with the central 5-... |
Brit.J.Pharmacol. |
1980 |
| Editorial |
Arguments Heard for Psychedelics Probe |
Science |
1980 |
| Luscombe G, Jenner P, Mar... |
Myoclonus In Guinea Pigs Is Induced By Indole-containing But Not Piper... |
Life Sciences |
1982 |
| Schmidt MJ, Root MA, Hall... |
Dopamine Agonist Induced Hyperglycemia In Rats: Structure-activity;sRe... |
Europ.J.Pharmacol. |
1983 |
| Weaver KEC |
Letters to the Editor: LSD and Schizophrenia |
Arch. Gen. Psychiatr... |
1984 |
| Schechter MD |
Use of TFMPP stimulus properties as a model of 5-HT1B receptor activat... |
Pharmacol Biochem Be... |
1988 |
| Appel JB, Callahan PM |
Involvement of 5-HT receptor subtypes in the discriminative stimulus p... |
Eur J Pharmacol |
1989 |
| Bilsky EJ, Hui YZ, Hubbel... |
Methylenedioxymethamphetamine's capacity to establish place preference... |
Pharmacol Biochem Be... |
1990 |
| Ricaurte GA, Finnegan KT,... |
Aminergic metabolites in cerebrospinal fluid of humans previously expo... |
Ann N Y Acad Sci |
1990 |
| Pan HS, Wang RY |
MDMA: further evidence that its action in the medial prefrontal cortex... |
Brain Res |
1991 |
| Duffield PH, Jamieson D |
Development of tolerance to kava in mice |
Clin Exp Pharmacol P... |
1991 |
| Wichems CH, Hollingsworth... |
Release of serotonin induced by 3,4-methylenedioxymethamphetamine (MDM... |
Brain Res |
1995 |
| Hanes KR |
Serotonin, psilocybin, and body dysmorphic disorder: a case report. |
J Clin Psychopharmac... |
1996 |
| Buydens-Branchey L, Branc... |
Hormonal, psychological, and alcohol craving changes after m-chlorophe... |
Alcohol Clin Exp Res |
1997 |
| Bengel D, Murphy DL, Andr... |
Altered brain serotonin homeostasis and locomotor insensitivity to 3, ... |
Mol Pharmacol |
1998 |
| Bai F, Lau SS, Monks TJ |
Glutathione and N-acetylcysteine conjugates of alpha-methyldopamine pr... |
Chem Res Toxicol |
1999 |
| McCann UD, Mertl M, Eligu... |
Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA... |
Psychopharmacology (... |
1999 |
| Baggott M, Mendelson J, J... |
More about parkinsonism after taking ecstasy |
N Engl J Med |
1999 |
| Burrows KB, Gudelsky G, Y... |
Rapid and transient inhibition of mitochondrial function following met... |
Eur J Pharmacol |
2000 |
| Al-Sahli W, Ahmad H, Kher... |
Effects of methylenedioxymethamphetamine on noradrenaline-evoked contr... |
Eur J Pharmacol |
2001 |
| Bhattachary S, Powell JH |
Recreational use of 3,4-methylenedioxymethamphetamine (MDMA) or 'ecsta... |
Psychol Med |
2001 |
| Croft RC, Macay AJ, Mills... |
The relative contributions of ecstasy and cannabis to cognitive impair... |
Psychopharmacology (... |
2001 |
| Verkes RJ, Gijsman HJ, Pi... |
Cognitive performance and serotonergic function in users of ecstasy |
Psychopharmacology (... |
2001 |
| Callahan BT, Cord BJ, Ric... |
Long-Term Impairment of Anterograde Axonal Transport Along Fiber Proje... |
Synapse |
2001 |
| Young R, Glennon RA |
The stimulus effect of 5,6,7,8-tetrahydro-1,3-dioxolo[4,5- g]isoquinol... |
Pharmacol Biochem Be... |
2002 |
| Klitzman RL, Greenberg JD... |
MDMA ('ecstasy') use, and its association with high risk behaviors, me... |
Drug Alcohol Depend |
2002 |
| Glennon RA, Young R, Rang... |
Further characterization of the stimulus properties of 5,6,7,8- tetrah... |
Pharmacol Biochem Be... |
2002 |
| Gouzoulis-Mayfrank E, The... |
Effects of the hallucinogen psilocybin on covert orienting of visual a... |
Neuropsychobiology |
2002 |
| Gouzoulis-Mayfrank E, The... |
Effects of the hallucinogen psilocybin on covert orienting of visual a... |
Neuropsychobiology |
2002 |
| Yuan J, Cord BJ, McCann U... |
Effect of glucoprivation on serotonin neurotoxicity induced by substit... |
J Pharmacol Exp Ther |
2002 |
| Cowan RL, Lyooa IK,Sunga ... |
Reduced cortical gray matter density in human MDMA (Ecstasy) users: a ... |
Drug and Alcohol Dep... |
2003 |
| Rodgers J, Buchanan T, Sc... |
Patterns of Drug Use and the Influence of Gender on Self-Reports of Me... |
J Psychopharmacology |
2003 |
| Daumann J, Hensen G, Thim... |
Self-reported psychopathological symptoms in recreational ecstasy (MDM... |
Psychopharmacology (... |
2004 |
| Farre M, De La Torre R, O... |
Repeated doses administration of MDMA in humans: pharmacological effec... |
Psychopharmacology (... |
2004 |
| Parks KA, Kennedy CL |
Club Drugs: Reasons for and Consequences of Use |
J Psychoactive Drugs |
2004 |
| de la Torre R, Farre M, M... |
Response to Sprague and Nichols: Contribution of metabolic activation ... |
Trends in Pharmacolo... |
2005 |
| LeBeau MA, Montgomery MA,... |
Further evidence of in vitro production of gamma-hydroxybutyrate (GHB)... |
Forensic Sci Int |
2007 |
| Marona-Lewicka D, Nichols... |
Further evidence that the delayed temporal dopaminergic effects of LSD... |
Pharmacol Biochem Be... |
2007 |
| Munro TA, Duncan KK, Xu W... |
Standard protecting groups create potent and selective kappa opioids: ... |
Bioorg Med Chem |
2008 |
| Starr MA, Page ME, Waterh... |
MDMA (3,4-methylenedioxymethamphetamine) - mediated distortion of soma... |
J Pharmacol Exp Ther |
2008 |
| Mueller MA, Yuan J, Neudo... |
Further Studies on the Role of Metabolites in MDMA-induced Serotonergi... |
Drug Metab Dispos |
2009 |
| Bisceglia KJ, Roberts AL,... |
Quantification of drugs of abuse in municipal wastewater via SPE and d... |
Anal Bioanal Chem |
2010 |
| Parrott AC |
Residual neurocognitive features of ecstasy use: a re-interpretation o... |
Addiction |
2011 |
| Halpern JH, Sherwood AR, ... |
Reply to Parrott (2011), Fisk et al (2011) and Rodgers et al (2011) |
Addiction |
2011 |
| Freyer CW, Peters M |
Palpable Purpura Complicated by Streptococcal Toxic Shock Syndrome Res... |
Pharmacotherapy |
2012 |
| Broman CL |
The Availability of Substances in Adolescence: Influences in Emerging ... |
Journal of Child & A... |
2016 |
| Saleemi S, Pennybaker SJ,... |
Who is 'Molly'? MDMA adulterants by product name and the impact of har... |
J Psychopharmacol |
2017 |
